| C029790 | 2,2',3',4,4',5-hexachlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of S100A11 mRNA" | 25510870 |
| C081766 | 2,4,4'-trichlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of S100A11 mRNA" | 25510870 |
| C014024 | 2,4,5,2',4',5'-hexachlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of S100A11 mRNA" | 25510870 |
| C009828 | 2,4,5,2',5'-pentachlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of S100A11 mRNA" | 25510870 |
| C009407 | 2,5,2',5'-tetrachlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of S100A11 mRNA" | 25510870 |
| C023514 | 2,6-dinitrotoluene | "2,6-dinitrotoluene results in increased expression of S100A11 mRNA" | 20406850 |
| C009505 | 4,4'-diaminodiphenylmethane | "4,4'-diaminodiphenylmethane results in increased expression of S100A11 mRNA" | 18648102 |
| C009505 | 4,4'-diaminodiphenylmethane | "4,4'-diaminodiphenylmethane results in increased expression of S100A11 mRNA" | 25380136 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A11 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A11 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A11 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A11 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A11 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A11 mRNA" | 27188386 |
| C065250 | 4-hydroxy-equilenin | 4-hydroxy-equilenin results in increased expression of S100A11 mRNA | 15135645 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A11 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A11 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A11 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A11 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A11 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A11 mRNA" | 27188386 |
| D000082 | Acetaminophen | Acetaminophen results in increased expression of S100A11 mRNA | 29067470 |
| D000082 | Acetaminophen | Acetaminophen affects the expression of S100A11 mRNA | 17562736 |
| D000082 | Acetaminophen | Acetaminophen results in increased expression of S100A11 mRNA | 24126418 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [[S100A11 mutant form results in increased susceptibility to Cisplatin] which results in increased cleavage of CASP3 protein] | 25940438 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [[S100A11 mutant form results in increased susceptibility to Cisplatin] which results in increased cleavage of CASP9 protein] | 25940438 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [[S100A11 mutant form results in increased susceptibility to Cisplatin] which results in increased cleavage of PARP1 protein] | 25940438 |
| D020106 | Acrylamide | Acrylamide results in decreased expression of S100A11 mRNA | 28959563 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 affects the expression of S100A11 protein | 20106945 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 results in increased expression of S100A11 mRNA | 27153756 |
| D000395 | Air Pollutants, Occupational | "Air Pollutants, Occupational results in decreased expression of S100A11 mRNA" | 23195993 |
| D013196 | Dihydrotestosterone | Dihydrotestosterone results in increased expression of S100A11 protein | 16751997 |
| C059765 | amphotericin B, deoxycholate drug combination | "amphotericin B, deoxycholate drug combination results in increased expression of S100A11 mRNA" | 22863853 |
| D018501 | Antirheumatic Agents | Antirheumatic Agents results in decreased expression of S100A11 mRNA | 24449571 |
| C081565 | arachidonyltrifluoromethane | arachidonyltrifluoromethane inhibits the reaction [S100A11 mutant form results in increased susceptibility to Cisplatin] | 25940438 |
| C081565 | arachidonyltrifluoromethane | arachidonyltrifluoromethane inhibits the reaction [S100A11 mutant form results in increased susceptibility to oxaliplatin] | 25940438 |
| D001151 | Arsenic | Arsenic affects the methylation of S100A11 gene | 25304211 |
| C006632 | arsenic trioxide | arsenic trioxide results in increased expression of S100A11 mRNA | 20458559 |
| D001241 | Aspirin | Aspirin results in decreased expression of S100A11 mRNA | 15928584 |
| D001379 | Azathioprine | Azathioprine results in increased expression of S100A11 mRNA | 22623647 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of S100A11 mRNA | 20106945|2163298 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of S100A11 mRNA | 19770486|2012785 |
| C517629 | benzyloxycarbonyl-valyl-alanyl-aspartic acid | benzyloxycarbonyl-valyl-alanyl-aspartic acid inhibits the reaction [[S100A11 mutant form results in increased susceptibility to Cisplatin] which results in increased cleavage of PARP1 protein] | 25940438 |
| C517629 | benzyloxycarbonyl-valyl-alanyl-aspartic acid | benzyloxycarbonyl-valyl-alanyl-aspartic acid inhibits the reaction [[S100A11 mutant form results in increased susceptibility to Fluorouracil] which results in increased cleavage of PARP1 protein] | 25940438 |
| D004958 | Estradiol | Estradiol results in increased expression of S100A11 mRNA | 20106945 |
| C006780 | bisphenol A | bisphenol A results in decreased expression of S100A11 mRNA | 28780062 |
| C006780 | bisphenol A | bisphenol A affects the expression of S100A11 mRNA | 25181051 |
| C006780 | bisphenol A | [Fructose co-treated with bisphenol A] results in increased expression of S100A11 protein | 26930160 |
| C423844 | BL 11282 | BL 11282 results in increased expression of S100A11 protein | 17458497 |
| D001761 | Bleomycin | Bleomycin results in increased expression of S100A11 protein | 25933445 |
| D002104 | Cadmium | Cadmium results in increased oxidation of S100A11 protein | 24077948 |
| D019256 | Cadmium Chloride | Cadmium Chloride results in decreased expression of S100A11 protein | 24419708 |
| D019256 | Cadmium Chloride | Cadmium Chloride results in increased expression of S100A11 protein | 24527689 |
| D019256 | Cadmium Chloride | Cadmium Chloride affects the expression of S100A11 mRNA | 22110744 |
| D002220 | Carbamazepine | Carbamazepine affects the expression of S100A11 mRNA | 25979313 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased expression of S100A11 mRNA | 16239168 |
| C043211 | carvedilol | carvedilol results in decreased expression of S100A11 protein | 20403466 |
| D002392 | Catechin | [Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of S100A11 mRNA | 24763279 |
| C100187 | chloropicrin | chloropicrin results in increased expression of S100A11 mRNA | 26352163 |
| D002794 | Choline | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of S100A11 mRNA | 20938992 |
| C055162 | clopidogrel | clopidogrel inhibits the reaction [Lipopolysaccharides results in increased expression of S100A11 mRNA] | 19172522 |
| C018021 | cobaltous chloride | cobaltous chloride results in decreased expression of S100A11 mRNA | 19376846 |
| C018021 | cobaltous chloride | cobaltous chloride results in increased expression of S100A11 mRNA | 24386269 |
| D019327 | Copper Sulfate | Copper Sulfate results in increased expression of S100A11 mRNA | 19549813 |
| D003471 | Cuprizone | Cuprizone results in increased expression of S100A11 mRNA | 26577399 |
| C057862 | cyanoginosin LR | cyanoginosin LR results in increased expression of S100A11 mRNA | 17654400 |
| D016572 | Cyclosporine | Cyclosporine results in increased expression of S100A11 mRNA | 20106945|2163298 |
| C014347 | decitabine | decitabine affects the expression of S100A11 mRNA | 23300844 |
| C014347 | decitabine | decitabine affects the methylation of S100A11 gene | 17579622 |
| D003907 | Dexamethasone | Dexamethasone inhibits the reaction [RX3 gene mutant form affects the expression of S100A11 mRNA] | 27941970 |
| D003907 | Dexamethasone | Dexamethasone results in decreased expression of S100A11 mRNA | 22733784 |
| C042577 | diallyl trisulfide | diallyl trisulfide results in increased expression of S100A11 protein | 16344271 |
| D002945 | Cisplatin | Acetylcysteine inhibits the reaction [[S100A11 mutant form results in increased susceptibility to Cisplatin] which results in increased cleavage of CASP3 protein] | 25940438 |
| D002945 | Cisplatin | Acetylcysteine inhibits the reaction [[S100A11 mutant form results in increased susceptibility to Cisplatin] which results in increased cleavage of CASP9 protein] | 25940438 |
| D002945 | Cisplatin | Acetylcysteine inhibits the reaction [[S100A11 mutant form results in increased susceptibility to Cisplatin] which results in increased cleavage of PARP1 protein] | 25940438 |
| D002945 | Cisplatin | arachidonyltrifluoromethane inhibits the reaction [S100A11 mutant form results in increased susceptibility to Cisplatin] | 25940438 |
| D002945 | Cisplatin | benzyloxycarbonyl-valyl-alanyl-aspartic acid inhibits the reaction [[S100A11 mutant form results in increased susceptibility to Cisplatin] which results in increased cleavage of PARP1 protein] | 25940438 |
| D002945 | Cisplatin | Cisplatin affects the expression of S100A11 mRNA | 23300844 |
| D002945 | Cisplatin | S100A11 mutant form promotes the reaction [Cisplatin results in increased cleavage of PARP1 protein] | 25940438 |
| D002945 | Cisplatin | S100A11 mutant form promotes the reaction [Cisplatin results in increased expression of H2AFX protein] | 25940438 |
| D002945 | Cisplatin | S100A11 mutant form results in increased susceptibility to Cisplatin | 25940438 |
| D002945 | Cisplatin | [S100A11 mutant form results in increased susceptibility to Cisplatin] which results in increased cleavage of CASP3 protein | 25940438 |
| D002945 | Cisplatin | [S100A11 mutant form results in increased susceptibility to Cisplatin] which results in increased cleavage of CASP9 protein | 25940438 |
| D002945 | Cisplatin | [S100A11 mutant form results in increased susceptibility to Cisplatin] which results in increased cleavage of PARP1 protein | 25940438 |
| D004041 | Dietary Fats | Dietary Fats results in increased expression of S100A11 mRNA | 22609946|2501614 |
| D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of S100A11 mRNA | 24535843 |
| D004052 | Diethylnitrosamine | Diethylnitrosamine results in increased expression of S100A11 mRNA | 24535843 |
| D004052 | Diethylnitrosamine | Diethylnitrosamine results in increased expression of S100A11 mRNA | 19638242 |
| D004128 | Dimethylnitrosamine | Dimethylnitrosamine results in increased expression of S100A11 mRNA | 25380136 |
| D004298 | Dopamine | Dopamine results in increased expression of S100A11 mRNA | 21983523 |
| D004317 | Doxorubicin | Doxorubicin affects the expression of S100A11 protein | 29385562 |
| D004791 | Enzyme Inhibitors | [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of S100A11 protein | 23301498 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in increased expression of S100A11 mRNA | 17942748 |
| D004997 | Ethinyl Estradiol | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of S100A11 mRNA | 17942748 |
| D018818 | Fenoldopam | Fenoldopam results in increased expression of S100A11 mRNA | 21983523 |
| D015073 | 2-Acetylaminofluorene | 2-Acetylaminofluorene results in increased expression of S100A11 mRNA | 17317680 |
| D005472 | Fluorouracil | benzyloxycarbonyl-valyl-alanyl-aspartic acid inhibits the reaction [[S100A11 mutant form results in increased susceptibility to Fluorouracil] which results in increased cleavage of PARP1 protein] | 25940438 |
| D005472 | Fluorouracil | S100A11 mutant form promotes the reaction [Fluorouracil results in increased cleavage of PARP1 protein] | 25940438 |
| D005472 | Fluorouracil | S100A11 mutant form results in increased susceptibility to Fluorouracil | 25940438 |
| D005472 | Fluorouracil | [S100A11 mutant form results in increased susceptibility to Fluorouracil] which results in increased activity of CASP3 protein | 25940438 |
| D005472 | Fluorouracil | [S100A11 mutant form results in increased susceptibility to Fluorouracil] which results in increased cleavage of PARP1 protein | 25940438 |
| D005472 | Fluorouracil | [S100A11 mutant form results in increased susceptibility to Fluorouracil] which results in increased expression of H2AFX protein | 25940438 |
| D005472 | Fluorouracil | Fluorouracil results in increased expression of S100A11 mRNA | 19272435 |
| D005492 | Folic Acid | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of S100A11 mRNA | 20938992 |
| D005632 | Fructose | [Fructose co-treated with bisphenol A] results in increased expression of S100A11 protein | 26930160 |
| C056933 | fumonisin B1 | fumonisin B1 results in increased expression of S100A11 mRNA | 16221962 |
| C039281 | furan | furan results in increased expression of S100A11 mRNA | 26194646 |
| D005839 | Gentamicins | Gentamicins results in increased expression of S100A11 mRNA | 22061828 |
| D005897 | Glafenine | Glafenine results in increased expression of S100A11 mRNA | 24136188 |
| C511402 | Grape Seed Proanthocyanidins | [Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of S100A11 mRNA | 24763279 |
| D006108 | Graphite | Graphite results in increased expression of S100A11 protein | 22157353 |
| D017313 | Fenretinide | Fenretinide results in decreased expression of S100A11 mRNA | 28973697 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in decreased expression of S100A11 mRNA | 26846883 |
| C492448 | ICG 001 | ICG 001 results in increased expression of S100A11 mRNA | 26191083 |
| C016517 | indole-3-carbinol | indole-3-carbinol affects the expression of S100A11 mRNA | 21396975 |
| D015759 | Ionomycin | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of S100A11 mRNA | 25613284 |
| D007545 | Isoproterenol | Isoproterenol results in increased expression of S100A11 protein | 10886724 |
| D007649 | Ketamine | Ketamine results in decreased expression of S100A11 mRNA | 20080153 |
| C029891 | lead chloride | lead chloride results in increased expression of S100A11 protein | 24419708 |
| C045463 | leflunomide | leflunomide results in decreased expression of S100A11 mRNA | 24136188 |
| C482199 | lipopolysaccharide, E coli O55-B5 | "lipopolysaccharide, E coli O55-B5 results in increased expression of S100A11 mRNA" | 24972896 |
| C482199 | lipopolysaccharide, E coli O55-B5 | "[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of S100A11 mRNA" | 18930950 |
| D008070 | Lipopolysaccharides | clopidogrel inhibits the reaction [Lipopolysaccharides results in increased expression of S100A11 mRNA] | 19172522 |
| C042720 | mercuric bromide | mercuric bromide results in increased expression of S100A11 mRNA | 26272509 |
| C042720 | mercuric bromide | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A11 mRNA" | 27188386 |
| D008694 | Methamphetamine | [Methamphetamine co-treated with SCH 23390] results in decreased expression of S100A11 mRNA | 19564919 |
| D008694 | Methamphetamine | Methamphetamine results in decreased expression of S100A11 mRNA | 19564919 |
| D008715 | Methionine | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of S100A11 mRNA | 20938992 |
| D008727 | Methotrexate | Methotrexate results in decreased expression of S100A11 mRNA | 17400583 |
| C004925 | methylmercuric chloride | methylmercuric chloride results in increased expression of S100A11 mRNA | 23458150 |
| C004925 | methylmercuric chloride | methylmercuric chloride results in decreased expression of S100A11 mRNA | 23179753 |
| C004925 | methylmercuric chloride | methylmercuric chloride results in increased expression of S100A11 mRNA | 28001369 |
| C045621 | miglitol | miglitol results in decreased expression of S100A11 mRNA | 20667563 |
| D016685 | Mitomycin | S100A11 protein affects the susceptibility to Mitomycin | 16217747 |
| C523799 | MRK 003 | S100A11 results in increased susceptibility to MRK 003 | 19903844 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon affects the expression of S100A11 protein" | 22001959 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon results in increased expression of S100A11 protein" | 22157353 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon analog results in increased expression of S100A11 mRNA" | 25554681 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon results in increased expression of S100A11 mRNA" | 25554681 |
| D015058 | 1-Naphthylisothiocyanate | 1-Naphthylisothiocyanate results in increased expression of S100A11 mRNA | 25380136 |
| D009532 | Nickel | Nickel results in decreased expression of S100A11 mRNA | 23195993 |
| C030110 | oxaliplatin | arachidonyltrifluoromethane inhibits the reaction [S100A11 mutant form results in increased susceptibility to oxaliplatin] | 25940438 |
| C030110 | oxaliplatin | S100A11 mutant form results in increased susceptibility to oxaliplatin | 25940438 |
| C030110 | oxaliplatin | [S100A11 mutant form results in increased susceptibility to oxaliplatin] which results in increased activity of CASP3 protein | 25940438 |
| C030110 | oxaliplatin | [S100A11 mutant form results in increased susceptibility to oxaliplatin] which results in increased cleavage of PARP1 protein | 25940438 |
| C496932 | panobinostat | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A11 mRNA" | 27188386 |
| C496932 | panobinostat | panobinostat results in increased expression of S100A11 mRNA | 26272509 |
| C410127 | PCB 180 | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of S100A11 mRNA" | 25510870 |
| D010634 | Phenobarbital | [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of S100A11 mRNA | 24535843 |
| D010662 | Phenylmercuric Acetate | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A11 mRNA" | 27188386 |
| D010662 | Phenylmercuric Acetate | Phenylmercuric Acetate results in increased expression of S100A11 mRNA | 26272509 |
| C006253 | pirinixic acid | [pirinixic acid co-treated with PPARA] results in increased expression of S100A11 mRNA | 20813756 |
| C006253 | pirinixic acid | pirinixic acid results in decreased expression of S100A11 mRNA | 17426115 |
| C006253 | pirinixic acid | pirinixic acid results in increased expression of S100A11 mRNA | 16221962|2081375 |
| C027373 | potassium chromate(VI) | potassium chromate(VI) results in decreased expression of S100A11 mRNA | 22714537 |
| D011441 | Propylthiouracil | Propylthiouracil results in increased expression of S100A11 mRNA | 24780913 |
| C513428 | pyrachlostrobin | pyrachlostrobin results in increased expression of S100A11 mRNA | 27029645 |
| D011794 | Quercetin | Quercetin results in increased expression of S100A11 mRNA | 21632981 |
| D012402 | Rotenone | Rotenone results in increased expression of S100A11 mRNA | 23186747 |
| C534628 | SCH 23390 | [Methamphetamine co-treated with SCH 23390] results in decreased expression of S100A11 mRNA | 19564919 |
| C534628 | SCH 23390 | SCH 23390 results in decreased expression of S100A11 mRNA | 19564919 |
| D012643 | Selenium | Selenium results in increased expression of S100A11 mRNA | 19244175 |
| D012715 | Sesame Oil | Sesame Oil results in decreased expression of S100A11 mRNA | 29191790 |
| D012822 | Silicon Dioxide | Silicon Dioxide results in increased expression of S100A11 mRNA | 23221170 |
| D012969 | Sodium Fluoride | Sodium Fluoride results in decreased expression of S100A11 protein | 28918527 |
| D012969 | Sodium Fluoride | Sodium Fluoride results in increased expression of S100A11 mRNA | 27862939 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of S100A11 mRNA | 20106945|2163298 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of S100A11 mRNA | 21570461 |
| D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of S100A11 mRNA | 17942748 |
| D013755 | Tetradecanoylphorbol Acetate | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of S100A11 mRNA | 25613284 |
| D013853 | Thioacetamide | Thioacetamide results in increased expression of S100A11 mRNA | 23411599 |
| C009495 | titanium dioxide | titanium dioxide results in increased expression of S100A11 mRNA | 23557971|2776080 |
| D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution results in decreased expression of S100A11 mRNA | 28065790 |
| D014212 | Tretinoin | Tretinoin results in increased expression of S100A11 mRNA | 21934132 |
| D014241 | Trichloroethylene | Trichloroethylene results in increased expression of S100A11 mRNA | 25549359 |
| C012589 | trichostatin A | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A11 mRNA" | 27188386 |
| C012589 | trichostatin A | trichostatin A results in increased expression of S100A11 mRNA | 24935251|2627250 |
| C016805 | tris(1,3-dichloro-2-propyl)phosphate | "tris(1,3-dichloro-2-propyl)phosphate results in increased expression of S100A11 mRNA" | 26179874 |
| C013320 | tris(2-butoxyethyl) phosphate | tris(2-butoxyethyl) phosphate affects the expression of S100A11 mRNA | 29024780 |
| C080163 | trovafloxacin | "[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of S100A11 mRNA" | 18930950 |
| D014635 | Valproic Acid | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A11 mRNA" | 27188386 |
| D014635 | Valproic Acid | Valproic Acid results in decreased expression of S100A11 mRNA | 29154799 |
| D014635 | Valproic Acid | Valproic Acid results in increased expression of S100A11 mRNA | 19101580|2317975 |
| D014635 | Valproic Acid | Valproic Acid results in increased expression of S100A11 mRNA | 24896083 |
| D014638 | Vanadates | Vanadates results in increased expression of S100A11 mRNA | 22714537 |
| D014640 | Vancomycin | Vancomycin results in decreased expression of S100A11 mRNA | 18930951 |
| D001335 | Vehicle Emissions | Vehicle Emissions results in increased methylation of S100A11 gene | 25560391 |
| C025643 | vinclozolin | vinclozolin affects the expression of S100A11 mRNA | 19015723 |
| C029297 | vinylidene chloride | vinylidene chloride results in increased expression of S100A11 mRNA | 26682919 |
| D014810 | Vitamin E | Vitamin E results in increased expression of S100A11 mRNA | 19244175 |
| C111237 | vorinostat | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A11 mRNA" | 27188386 |
| C111237 | vorinostat | vorinostat results in increased expression of S100A11 mRNA | 26272509 |